Evidence map›Paper›PMID 42484507›Full record

ArticleLower urinary tract symptoms2026

Probabilistic Multicriteria Decision Analysis of Minimally Invasive Treatments for Benign Prostatic Obstruction: A Secondary Analysis of Network Meta-Analysis Data.

Shugo Yajima, Soichiro Yoshida, Wei Chen, Hiroshi Fukushima, Yuma Waseda, Hajime Tanaka, Hiroyuki Sato, Akihiro Hirakawa, Hitoshi Masuda, Yasuhisa Fujii

Abstract readNetwork Meta-Analysis
PubMed Full text at PMC Publisher
In one paragraph

Article in Lower urinary tract symptoms, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shugo YajimaDepartment of Urology, National Cancer Center Hospital East, Chiba, Japan.ORCID https://orcid.org/0000-0003-2300-8446
Soichiro YoshidaDepartment of Urology, Institute of Science Tokyo, Tokyo, Japan.ORCID https://orcid.org/0000-0003-2757-8083
Wei ChenDepartment of Urology, Institute of Science Tokyo, Tokyo, Japan.ORCID https://orcid.org/0000-0003-2275-4527
Hiroshi FukushimaDepartment of Urology, Institute of Science Tokyo, Tokyo, Japan.ORCID https://orcid.org/0000-0001-7548-1580
Yuma WasedaDepartment of Urology, Institute of Science Tokyo, Tokyo, Japan.ORCID https://orcid.org/0000-0002-9319-1373
Hajime TanakaDepartment of Urology, Institute of Science Tokyo, Tokyo, Japan.ORCID https://orcid.org/0000-0003-3632-2901
Hiroyuki SatoDepartment of Clinical Biostatistics, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan.ORCID https://orcid.org/0000-0002-9507-9887
Akihiro HirakawaDepartment of Clinical Biostatistics, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan.ORCID https://orcid.org/0000-0003-2580-7460
Hitoshi MasudaDepartment of Urology, National Cancer Center Hospital East, Chiba, Japan.ORCID https://orcid.org/0000-0002-9182-8481
Yasuhisa FujiiDepartment of Urology, Institute of Science Tokyo, Tokyo, Japan.ORCID https://orcid.org/0000-0002-6761-3229

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo compare minimally invasive surgical therapies (MISTs) for benign prostatic obstruction (BPO) using probabilistic multicriteria decision analysis that integrates heterogeneous clinical outcomes under varying stakeholder priorities.

methodsThis secondary analysis was derived from a published network meta-analysis. Three treatments-monopolar transurethral resection of the prostate (mTURP), prostatic urethral lift (PUL), and water vapor thermal therapy (WVTT)-were compared across six criteria: International Prostate Symptom Score (IPSS), IPSS Quality of Life, maximum urinary flow rate (Q

resultsUnder equal weights, WVTT had the highest P(best) (54.1%), followed by mTURP (25.8%) and PUL (20.1%); all pairwise UIs crossed zero. Under efficacy weights, mTURP had the highest P(best) (88.0%; net advantage vs. PUL: 0.124, 95% UI: 0.034-0.214), driven by superiority in Q

conclusionWithin short-term (3-6 month) data, MIST preference for BPO depends on clinical priorities. mTURP is favored when urodynamic outcomes are emphasized; PUL and WVTT are preferred when preservation of sexual function is prioritized. This framework supports preference-sensitive shared decision-making, although the findings are provisional pending long-term data.

Indexed as

Decision Support TechniquesMinimally Invasive Surgical ProceduresProstatic HyperplasiaHumansMaleMonte Carlo MethodQuality of LifeTransurethral Resection of ProstateTreatment Outcomedecision support techniquesMonte Carlo methodnetwork meta‐analysisprostatic hyperplasiatransurethral resection of prostate

Identifiers

PMID42484507
PMCPMC13390660

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.